Free Trial

Ingevity Co. (NYSE:NGVT) Position Lifted by Villanova Investment Management Co LLC

Ingevity logo with Basic Materials background
Remove Ads

Villanova Investment Management Co LLC boosted its holdings in Ingevity Co. (NYSE:NGVT - Free Report) by 17.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 57,104 shares of the company's stock after purchasing an additional 8,645 shares during the quarter. Ingevity makes up 2.1% of Villanova Investment Management Co LLC's portfolio, making the stock its 17th biggest holding. Villanova Investment Management Co LLC owned approximately 0.16% of Ingevity worth $2,327,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. KBC Group NV raised its position in shares of Ingevity by 27.5% in the 4th quarter. KBC Group NV now owns 2,007 shares of the company's stock worth $82,000 after buying an additional 433 shares during the period. Arizona State Retirement System raised its holdings in shares of Ingevity by 6.1% in the 4th quarter. Arizona State Retirement System now owns 10,550 shares of the company's stock worth $430,000 after purchasing an additional 611 shares during the period. Johnson Investment Counsel Inc. lifted its stake in shares of Ingevity by 9.1% in the 4th quarter. Johnson Investment Counsel Inc. now owns 7,538 shares of the company's stock valued at $307,000 after purchasing an additional 628 shares in the last quarter. Hudson Edge Investment Partners Inc. grew its holdings in shares of Ingevity by 4.9% during the 4th quarter. Hudson Edge Investment Partners Inc. now owns 16,150 shares of the company's stock worth $658,000 after purchasing an additional 750 shares during the period. Finally, PNC Financial Services Group Inc. increased its position in Ingevity by 6.8% during the 4th quarter. PNC Financial Services Group Inc. now owns 12,097 shares of the company's stock worth $493,000 after purchasing an additional 765 shares in the last quarter. 91.59% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Ingevity Stock Down 9.5 %

Shares of NYSE NGVT traded down $3.30 during trading on Friday, reaching $31.37. 415,306 shares of the stock were exchanged, compared to its average volume of 269,340. The company has a market capitalization of $1.14 billion, a price-to-earnings ratio of -2.65 and a beta of 1.52. The business's 50-day moving average price is $44.11 and its 200 day moving average price is $42.54. The company has a quick ratio of 1.04, a current ratio of 1.87 and a debt-to-equity ratio of 6.86. Ingevity Co. has a twelve month low of $30.13 and a twelve month high of $56.30.

Ingevity (NYSE:NGVT - Get Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The company reported $0.95 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.66. The firm had revenue of $298.80 million for the quarter, compared to analyst estimates of $297.40 million. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. As a group, equities analysts forecast that Ingevity Co. will post 4.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on NGVT. StockNews.com upgraded shares of Ingevity from a "hold" rating to a "buy" rating in a research note on Friday. BMO Capital Markets raised shares of Ingevity from a "market perform" rating to an "outperform" rating and upped their price target for the stock from $62.00 to $65.00 in a research report on Wednesday, February 26th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $55.17.

Get Our Latest Stock Report on NGVT

Ingevity Company Profile

(Free Report)

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.

See Also

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Should You Invest $1,000 in Ingevity Right Now?

Before you consider Ingevity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingevity wasn't on the list.

While Ingevity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads